Inventors:
Paul Zupkas - San Diego CA, US
Charles Parsons - San Diego CA, US
International Classification:
A61K 31/737, A61K 31/728, A61K 31/727, A61K 31/24
US Classification:
424423000, 514054000, 514056000, 514536000
Abstract:
Transluminal drug delivery method and device embodiments may include a urethral suppository formulated to treat diseases of the urethra and surrounding organs by enhancing the absorption of a therapeutic agent of the suppository into body tissues without adversely affecting the natural defense mechanisms of these tissues. Adverse affects on the glucosaminoglycan (GAG) barrier by the suppository may be mitigated or eliminated by the presence of a suitable polysaccharide in the suppository.